About anhehhed bioscenension ipo
IPO is an offer for sale (OFS) and composed stake to RS 1,325 crores can be offloaded with LLP viridity tone and to Rs 320 crores (invested in shareholders).
It also includes stake sales at Rs 320 crores each of Malay J Barua, Satish Sharma, to Prahorash Kariebettan and to K Ramakrishnan.
About bierciences in anheghed
The business of the song contains contract research research, development and manufacture of the CRDMO organization) and the production of making and selling specialty substances. It offers a comprehensive, integrated and more customized CRDMO services to the whole new chemical entity (NCE) and new biological entity (NBE) liftercycles.
The company claims to have a strong presence of various modalities, such as RNAI, ADC, ferrational fencing technologies and fermontowors, offering a wide range of technology development.
It also produces and sold the complex specialist based fermemaceutical components (Apix), including probiotics, enzymes, wrist goods, nutritional analogues and biosimilarities.
Ajay Bhardwaj (Chairman, MD & CEO), Ganesh Sambasivam (Whole Scientific Officer), the Chief Chanater of the Company (the Chief Chanater) is the chief chandors in India, with two operating facilities. Chandors) are the company’s promotions.The chief chandors in India, with the company’s own chief chanater) is the Indian company’s chief chanater, with two Indian company facilities, the unit i. Expand the personal capacity of synthesis by 25kl and fermentation capacity by 40kl by construction of unit III (wish to be fully limited to the first half of fiscal 2026.
Post-Expensions progressive activities, the united annual capacity of synthesis synthesis and fermentation development is expected to increase 425 kL and 182 kl, indeed. Fermentation capacity of 182 KL is expected to be more than six times the capacity of the second largest player in this industry, according to the F & S Report.
Song’s Financials
Income from operations increased by 30% to Rs 1,844 crores of FY25 from Rs 1,419 crores of FY24. Pat for the year ended March 31, 2025 is Rs 451 crores, a jump of 22.86% of FY24.
SAI Life Sciences Limited, LIMITED INTERNATIONAL INTERNATIONAL,, Cohace LifeScience is limited(Formerly suvenes pharmaceutical) and Laboratories in Divi limited peers in Anthem’s licenses, as their RHP.
BIORCIENCE IN ANHHEDHEDIENCE NEGE DEADER
The book running lead managers with managers JM is limitedCitigroup Global Markets India Private Limited, JP Morgan India Private Little Speritory and Securities (India) privately limited.
Equity features are proposed to be listed by BSE and NSE.
(Disclaim: Recommendations, suggestions, views and opinions given to experts themselves. It does not represent economic views
